Further buttressing the primary role of hepatic insulin clearance in insulin resistance, global Ceacam1 null mice manifest reduction in insulin clearance at 2 months of age, followed by systemic insulin resistance at 6–7 months of age and hepatic steatosis. This evidence concerns the gene CEACAM1 and fatty liver disease.